Device / Technology News

RSS

BioSilta releases EnPresso tablet that regulates protein production in recombinant bacteria

BioSilta announces the release of the EnPresso Tablet Cultivation Set, a tabletised form of the patented EnBase technology. The EnBase technology is based on providing an enzymatic-controlled glucose supply in a fed-batch type manner, which allows an extended growth period and promotes higher final cell density.

27 Oct 2010

Scientists develop new imaging technique that can detect breast cancer treatment response

Cancer Research UK scientists have developed a new imaging technique that can show when breast cancer treatment is working, weeks before current methods. The research is published in the British Journal of Cancer today1 (Wednesday).

27 Oct 2010

Study finds passive safety engineered devices effective for NSI prevention

A landmark study of 22 million safety devices used in 61 French hospitals over a two-year period has confirmed the theory that passive, fully automatic safety devices offer significantly better protection against accidental needlestick injuries (NSIs) than early generation active safety technologies such as semi-automatic (push-button) devices or those with manually sliding shields or hinged caps.

From B. Braun Melsungen AG 27 Oct 2010

New York DOH and NYeC plan to create country's largest network for EHRs

The New York Department of Health (DOH) and public-private partnership New York eHealth Collaborative (NYeC) on Tuesday presented a plan to change the face of health care for all New Yorkers by creating the country's largest network for electronic medical records.

27 Oct 2010

ENDOMETRIN Vaginal Insert offers effective luteal support in IVF procedures

Ferring Pharmaceuticals Inc. presented study results demonstrating that ENDOMETRIN (progesterone) Vaginal Insert provides effective luteal support compared to intramuscular (IM) progesterone-in-oil (PIO) in patients undergoing in vitro fertilization (IVF) using gonadotropin releasing hormone (GnRH) antagonist.

27 Oct 2010

PSA test helps detect prostate cancer before it spreads

In addition to saving lives, a new study indicates routine prostate-specific antigen (PSA) testing improves quality of life by substantially reducing the risk that prostate cancer will spread to other parts of the body.

27 Oct 2010

PCT technology improves DNA extraction method in forensic evidentiary samples

Pressure BioSciences, Inc. today announced that two scientific presentations at the 21st International Symposium on Human Identification have provided further evidence that pressure cycling technology offers an improved method for the extraction of DNA in the analysis of forensic evidentiary samples.

27 Oct 2010

CJPS Medical releases VitalPoint device to improve healthcare

CJPS Medical Systems releases VitalPoint this week, a medical device capable of measuring patients' vital signs from home, while allowing direct communication with their caregiver, and generating and saving HIPAA-compliant electronic medical records.

27 Oct 2010

CHI releases new white paper on 510(k) review process

California Healthcare Institute today announced the release of a new white paper titled "Upcoming Changes to the 510(k) Process: New Approval Pathways and the Impact on Medical Device Development and Innovation." CHI is a non-profit public policy research and advocacy organization, representing leading California academic institutions, biotechnology, medical device, diagnostics and pharmaceutical firms.

27 Oct 2010

Study: lncRNA are involved in host response to viral infection

Scientists have demonstrated for the first time that a certain class of RNA (known as long non-protein-coding RNA [lncRNA]) are involved in the host response to viral infection. These findings, published today in the online journal mBio-, could greatly change the way scientists look at the body's response to viral infection.

27 Oct 2010

New G-DOC repository for biological information

Georgetown Lombardi Comprehensive Cancer Center, part of Georgetown University Medical Center, announces the launch of the Georgetown Database of Cancer or G-DOC. Under development for two years, G-DOC is a repository for biological information that is normally only available in scattered information libraries and tissue banks, if at all. Data sets grow as researchers deposit new information. G-DOC also contains relevant tools to analyze the data, plus new ones not seen before.

27 Oct 2010

Study suggests need to explore new infertility tests

The method used to assess infertility in at-home tests might not be the best for identifying which women will have trouble getting pregnant, according to new research from the University of North Carolina at Chapel Hill School of Medicine.

27 Oct 2010

HIFU technology effective for treating metastatic liver cancer

EDAP TMS SA the global leader in therapeutic ultrasound, reported today successful completion of the first phase of the clinical protocol aimed at evaluating High Intensity Focused Ultrasound (HIFU) technology in patients with metastatic liver cancer. HIFU has the potential to destroy liver tumors through ablation and to reduce bleeding during surgery.

27 Oct 2010

Telehealth Monitoring System improves health outcomes in patients with chronic diseases

Patients with Chronic Obstructive Pulmonary Disease (COPD), Congestive Heart Failure (CHF), Diabetes, and wounds are often treated and stabilized in a hospital setting then discharged to continue care at home under the supervision of a Certified Home Health Care Agency. Many high risk patients can now be monitored at home through a Telehealth Monitoring System.

27 Oct 2010

New Australian start-up venture could lead to a revolution in personalized medicine

Pharmaceuticals that seek out cancerous cells and deliver treatments to them; imaging techniques that can help doctors detect diseases before the physical signs begin to appear; and medicines that are tailor-made for individual patients, are within the sights of an exciting new Australian start-up venture.

27 Oct 2010

Myriad signs agreement with Abbott for BRACAnalysis test

Myriad Genetics, Inc. today announced that it has signed an agreement with Abbott Laboratories, a global health care company, to conduct BRCA1 and BRCA2 mutation testing on patients to be enrolled in a Phase III multi-center, multi-national clinical study of a novel drug candidate for the treatment of metastatic breast cancer.

27 Oct 2010

New portable scanner for breast cancer diagnosis

Professor Zhipeng Wu has invented a portable scanner based on radio frequency technology, which is able to show in a second the presence of tumours malignant and benign in the breast on a computer.

From The University of Manchester 27 Oct 2010

Addition of ECC probe to SOLiD System's chemistry achieves greater than 99.99% single-read accuracy

Life Technologies Corporation a provider of innovative life science solutions, today announced that it has established a new standard in accuracy for next generation sequencing. By adding an Exact Call Chemistry (ECC) proprietary probe to its market leading ligation chemistry, the company has demonstrated greater than 99.99% average single-read accuracy.

27 Oct 2010

Verenium extends marketing agreement with Alfa Laval for Purifine PLC enzyme

Verenium Corporation a pioneer in the development and commercialization of high-performance enzyme solutions, today announced that it has renewed and extended its joint marketing agreement with Alfa Laval, a leading global provider of heat transfer, separation and fluid handling technologies, for Purifine PLC.

27 Oct 2010

Columbia University researchers to use IBM's streaming analytics to detect complications in brain injury

IBM today announced a new project in which researchers at Columbia University Medical Center will utilize IBM's streaming analytics technology to potentially detect severe complications in brain injured patients up to 48 hours earlier than traditional methods.

27 Oct 2010